Overview

Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management

Status:
Recruiting
Trial end date:
2021-12-03
Target enrollment:
Participant gender:
Summary
Assessment of the Effectiveness of Niclosamide as Add on Therapy to the Standard of care Measures in COVID-19 Management in a randomized controlled clinical trial
Phase:
Phase 2
Details
Lead Sponsor:
University of Baghdad
Treatments:
Niclosamide